$LLY

Rich Habits on $LLY (Oct 2, 2026)

AI summary · Rich Habits

LLY's Retatrotide drug (28% weight loss) drove a 25-28% profit on the speaker's LLY position; the drug is generating significant positive buzz.

Bullish
“Leaked Anthropic Financials, Oura Ring Delays IPO, & America.gov”
Rich HabitsPublished Oct 2 · 3 passages

Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy

Jump to any passage

3 passages

You know that you will lose 20% of your weight using one of these GLP-1 drugs, from Eli Lilly, Novo Nordisk , or Regeneron.

Eli Lilly's retatrotide drug achieved a 28% weight loss, with patients reporting improvements in daily mobility.

As for Eli Lilly, I made a profit of 25 to 28% in my position in Eli Lilly because they are the ones behind Retatrotide. The drug retatrodide is causing a huge stir online. People have been loving this medicine a lot lately.

What this channel has said about $LLY

Rich Habits has 2 calls on this stock; only the adjacent ones are shown.

TickerSays